| St Ottos Care Center | |
| 920 Southeast 4th Street, Little Falls, Minnesota 56345 | |
| (320) 632-9281 | |
| Name | St Ottos Care Center |
|---|---|
| Location | 920 Southeast 4th Street, Little Falls, Minnesota |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 91 |
| Occupancy Rate | 83.52% |
| Medicare ID (CCN) | 245257 |
| Legal Business Name | St Ottos Care Center Inc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1013184647 |
| Organization Name | ST. OTTO'S CARE CENTER INC |
| Doing Business As | ST. OTTO'S CARE CENTER |
| Address | 920 4th St Se, Little Falls, MN 56345 |
| Phone Number | 320-632-9281 |
News Archive
Because half of all instances of hearing loss are linked to genetic mutations, advanced gene research is an invaluable tool for uncovering causes of deafness - and one of the biggest hopes for the development of new therapies. Now Prof. Karen Avraham of the Sackler Faculty of Medicine at Tel Aviv University has discovered a significant mutation in a LINC family protein - part of the cells of the inner ear - that could lead to new treatments for hearing disorders.
For children and adolescents who require medication to treat anxiety, there are two primary classes of antidepressants that are prescribed: selective serotonin reuptake inhibitors and selective serotonin-norepinephrine reuptake inhibitors.
CytRx Corporation, a biopharmaceutical company, today announced plans to initiate a multinational Phase 2 clinical trial with its doxorubicin prodrug INNO-206 as a treatment for patients with advanced soft tissue sarcomas who have failed surgery and radiation. Soft tissue sarcomas are cancers that are formed in the muscle, fat, fibrous tissue, blood vessels or other supporting tissue of the body.
QIAGEN N.V. recognized the annual World TB Day 2019 held on March 24 by highlighting its growing global commitment to preventive screening and treatment for latent tuberculosis (TB) infection, a widespread condition that can lead to active TB disease in vulnerable patients.
An analysis published in the Journal of the European Academy of Dermatology and Venereology revealed considerable sex differences when considering links between psoriasis and metabolic disorders.
› Verified 5 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Because half of all instances of hearing loss are linked to genetic mutations, advanced gene research is an invaluable tool for uncovering causes of deafness - and one of the biggest hopes for the development of new therapies. Now Prof. Karen Avraham of the Sackler Faculty of Medicine at Tel Aviv University has discovered a significant mutation in a LINC family protein - part of the cells of the inner ear - that could lead to new treatments for hearing disorders.
For children and adolescents who require medication to treat anxiety, there are two primary classes of antidepressants that are prescribed: selective serotonin reuptake inhibitors and selective serotonin-norepinephrine reuptake inhibitors.
CytRx Corporation, a biopharmaceutical company, today announced plans to initiate a multinational Phase 2 clinical trial with its doxorubicin prodrug INNO-206 as a treatment for patients with advanced soft tissue sarcomas who have failed surgery and radiation. Soft tissue sarcomas are cancers that are formed in the muscle, fat, fibrous tissue, blood vessels or other supporting tissue of the body.
QIAGEN N.V. recognized the annual World TB Day 2019 held on March 24 by highlighting its growing global commitment to preventive screening and treatment for latent tuberculosis (TB) infection, a widespread condition that can lead to active TB disease in vulnerable patients.
An analysis published in the Journal of the European Academy of Dermatology and Venereology revealed considerable sex differences when considering links between psoriasis and metabolic disorders.
› Verified 5 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 22.92 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 7.38 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 39.39 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 4.31 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 4.35 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0.39 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 8.16 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 90.43 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 12.96 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 81.87 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 31.37 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 12.4 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 6.47 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.68 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 65.8 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 75.53 | 82.93 |
News Archive
Because half of all instances of hearing loss are linked to genetic mutations, advanced gene research is an invaluable tool for uncovering causes of deafness - and one of the biggest hopes for the development of new therapies. Now Prof. Karen Avraham of the Sackler Faculty of Medicine at Tel Aviv University has discovered a significant mutation in a LINC family protein - part of the cells of the inner ear - that could lead to new treatments for hearing disorders.
For children and adolescents who require medication to treat anxiety, there are two primary classes of antidepressants that are prescribed: selective serotonin reuptake inhibitors and selective serotonin-norepinephrine reuptake inhibitors.
CytRx Corporation, a biopharmaceutical company, today announced plans to initiate a multinational Phase 2 clinical trial with its doxorubicin prodrug INNO-206 as a treatment for patients with advanced soft tissue sarcomas who have failed surgery and radiation. Soft tissue sarcomas are cancers that are formed in the muscle, fat, fibrous tissue, blood vessels or other supporting tissue of the body.
QIAGEN N.V. recognized the annual World TB Day 2019 held on March 24 by highlighting its growing global commitment to preventive screening and treatment for latent tuberculosis (TB) infection, a widespread condition that can lead to active TB disease in vulnerable patients.
An analysis published in the Journal of the European Academy of Dermatology and Venereology revealed considerable sex differences when considering links between psoriasis and metabolic disorders.
› Verified 5 days ago
St Ottos Care Center Location: 920 Southeast 4th Street, Little Falls, Minnesota 56345 Phone: (320) 632-9281 | |
Little Falls Care Center Location: 1200 First Avenue Northeast, Little Falls, Minnesota 56345 Phone: (320) 632-9211 |